Rockefeller Capital Management’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $431K | Sell |
|
|||||
|
2025
Q2 | $409K | Buy |
|
|||||
|
2025
Q1 | $351K | Buy |
|
|||||
|
2024
Q4 | $519K | Buy |
|
|||||
|
2024
Q3 | $312K | Buy |
|
|||||
|
2024
Q2 | $284K | Buy |
|
|||||
|
2024
Q1 | $433K | Buy |
|
|||||
|
2023
Q4 | $289K | Sell |
|
|||||
|
2023
Q3 | $382K | Buy |
|
|||||
|
2023
Q2 | $253K | Sell |
|
|||||
|
2023
Q1 | $261K | Hold |
|
|||||
|
2022
Q4 | $156K | Sell |
|
|||||
|
2022
Q3 | $166K | Buy |
|
|||||
|
2022
Q2 | $188K | Buy |
|
|||||
|
2022
Q1 | $405K | Buy |
|
|||||
|
2021
Q4 | $0 | Hold |
|
|||||
|
2021
Q3 | $0 | Hold |
|
|||||
|
2021
Q2 | $0 | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $34K | Buy |
|